Tonix Pharmaceuticals Holding Balance Sheet (2022-2026) | TNXP

Balance Sheet Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 120.47M71.97M25.62M6.91M25.85M7.05M4.16M28.23M99.68M131.72M125.33M190.06M207.64M155.10M
Cash & Current Investments (Quarter) 120.47M71.97M25.62M6.91M25.85M7.05M4.16M28.23M99.68M131.72M125.33M190.06M207.64M155.10M
Receivables - Net (Quarter) 1.56M4.59M3.34M1.63M3.68M3.31M2.32M3.48M6.27M8.82M
Receivables - Other (Quarter) 8.04M1.56M0.76M4.59M2.50M1.59M0.88M0.23M2.02M1.67M3.48M2.17M
Receivables (Quarter) 2.32M9.18M3.34M3.22M4.56M3.54M4.34M5.15M9.76M10.99M
Raw Materials (Quarter) 3.61M3.35M3.07M2.65M2.35M2.48M2.51M
Work In Process (Quarter) 2.54M1.95M0.21M0.66M1.27M1.49M1.37M
Finished Goods (Quarter) 7.49M2.63M5.12M4.82M2.37M1.76M2.14M
Inventory (Quarter) 13.70M13.32M13.64M12.35M9.46M0.34M8.41M8.14M5.99M5.73M1.00M1.00M
Prepaid Assets (Quarter) 1.27M11.75M12.01M9.54M9.18M10.70M8.34M0.34M0.38M1.07M0.69M1.75M8.96M9.23M
Current Assets (Quarter) 130.78M83.73M51.33M31.34M47.77M30.10M25.29M50.54M119.00M149.57M143.53M208.07M228.88M207.17M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 93.81M93.99M95.72M94.87M94.03M93.06M43.25M42.75M42.25M41.77M42.34M42.57M44.46M44.89M
Goodwill (Quarter) 0.96M0.96M0.96M0.96M
Intangibles (Quarter) 0.12M10.22M9.86M9.62M9.38M0.12M0.12M0.12M0.12M0.12M0.12M0.12M0.12M
Goodwill & Intangibles (Quarter) 0.12M11.19M10.83M10.59M10.35M0.12M0.12M0.12M0.12M0.12M0.12M0.12M0.12M
Other Non-Current Assets (Quarter) 0.26M0.39M0.29M1.05M1.13M0.96M0.96M0.95M0.95M0.90M0.93M1.30M2.17M0.01M
Non-Current Assets (Quarter) 94.91M95.36M108.41M107.94M106.69M105.25M45.02M44.45M43.89M43.30M43.82M44.37M48.30M50.74M
Assets (Quarter) 225.69M179.09M159.74M139.28M154.46M135.34M70.31M94.99M162.89M192.87M187.36M252.44M277.17M257.91M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 8.07M4.62M7.67M9.50M12.48M6.65M8.54M3.94M4.55M4.19M11.08M12.33M22.60M9.65M
Payables (Quarter) 8.07M4.62M7.67M9.50M12.48M6.65M8.54M3.94M4.55M4.19M11.08M12.33M22.60M9.65M
Accumulated Expenses (Quarter) 0.03M0.04M0.03M
Short term Debt (Quarter) 2.35M2.82M2.82M2.82M2.82M
Current Leases (Quarter) 0.43M0.44M0.44M0.43M0.27M0.28M0.28M0.28M0.27M0.23M0.20M0.16M0.12M0.16M
Current Deferred Revenue (Quarter) 3.27M2.98M1.82M1.93M3.01M2.67M3.42M4.23M
Total Current Liabilities (Quarter) 18.18M13.07M18.44M17.73M18.88M20.48M22.04M15.18M18.31M12.15M19.06M21.03M30.84M29.65M
Non-Current Liabilities
Non-Current Debt (Quarter) 6.56M6.16M5.67M5.17M4.67M
Operating Leases (Quarter) 0.33M0.53M0.90M0.90M0.63M0.56M0.77M0.42M0.36M0.56M0.30M0.27M1.18M1.29M
Other Non-Current Liabilities (Quarter) 8.26M
Total Non-Current Liabilities (Quarter) 40.67M
Total Liabilities (Quarter) 18.51M13.66M19.27M18.45M48.93M27.20M28.20M20.78M23.33M12.47M19.36M21.30M32.02M30.77M
Shareholder's Equity
Total Debt (Quarter) 8.91M8.98M8.49M7.99M7.49M
Common Equity (Quarter) 207.18M165.43M140.46M120.83M105.53M108.14M42.10M74.21M139.56M180.40M168.00M231.14M245.15M227.14M
Shareholder's Equity (Quarter) 207.18M165.43M140.46M120.83M105.53M108.14M42.10M74.21M139.56M180.40M168.00M231.14M245.15M227.14M
Liabilities and Shareholders Equity (Quarter) 225.69M179.09M159.74M139.28M154.46M135.34M70.31M94.99M162.89M192.87M187.36M252.44M277.17M257.91M
Retained Earnings (Quarter) -0.17M-516.99M-545.36M-0.22M-0.23M-615.60M-0.24M-708.59M-730.69M-0.27M-0.27M-0.27M-854.72M-894.91M
Treasury Shares (Quarter) 0.08M0.25M